122 related articles for article (PubMed ID: 34533030)
1. Overexpression of BMP9 promotes ovarian cancer progression via Notch1 signaling.
Yang L; Bai Y; Zhang C; Du J; Cheng Y; Wang Q; Zhang B; Yang Y
Neoplasma; 2021 Nov; 68(6):1190-1200. PubMed ID: 34533030
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA GClnc1 knockdown suppresses progression of epithelial ovarian cancer by recruiting FOXC2 to disrupt the NOTCH1/NF-κB/Snail pathway.
Wu D; Ke Y; Xiao R; Liu J; Li Q; Wang Y
Exp Cell Res; 2021 Feb; 399(1):112422. PubMed ID: 33338479
[TBL] [Abstract][Full Text] [Related]
3. BMP9 inhibits the proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis via the PI3K/AKT signaling pathway.
Song B; Li XF; Yao Y; Xu QQ; Meng XM; Huang C; Li J
Int Immunopharmacol; 2019 Sep; 74():105685. PubMed ID: 31203157
[TBL] [Abstract][Full Text] [Related]
4. Targeting BMP9-promoted human osteosarcoma growth by inactivation of notch signaling.
Li R; Zhang W; Cui J; Shui W; Yin L; Wang Y; Zhang H; Wang N; Wu N; Nan G; Chen X; Wen S; Deng F; Zhang H; Zhou G; Liao Z; Zhang J; Zhang Q; Yan Z; Liu W; Zhang Z; Ye J; Deng Y; Luu HH; Haydon RC; He TC; Deng ZL
Curr Cancer Drug Targets; 2014; 14(3):274-85. PubMed ID: 24605944
[TBL] [Abstract][Full Text] [Related]
5. BMP9-ID1 signaling promotes EpCAM-positive cancer stem cell properties in hepatocellular carcinoma.
Chen H; Nio K; Yamashita T; Okada H; Li R; Suda T; Li Y; Doan PTB; Seki A; Nakagawa H; Toyama T; Terashima T; Iida N; Shimakami T; Takatori H; Kawaguchi K; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
Mol Oncol; 2021 Aug; 15(8):2203-2218. PubMed ID: 33834612
[TBL] [Abstract][Full Text] [Related]
6. BMP9 is a proliferative and survival factor for human hepatocellular carcinoma cells.
Herrera B; García-Álvaro M; Cruz S; Walsh P; Fernández M; Roncero C; Fabregat I; Sánchez A; Inman GJ
PLoS One; 2013; 8(7):e69535. PubMed ID: 23936038
[TBL] [Abstract][Full Text] [Related]
7. Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation.
Herrera B; van Dinther M; Ten Dijke P; Inman GJ
Cancer Res; 2009 Dec; 69(24):9254-62. PubMed ID: 19996292
[TBL] [Abstract][Full Text] [Related]
8. DLL4/Notch1 and BMP9 Interdependent Signaling Induces Human Endothelial Cell Quiescence via P27KIP1 and Thrombospondin-1.
Rostama B; Turner JE; Seavey GT; Norton CR; Gridley T; Vary CP; Liaw L
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2626-37. PubMed ID: 26471266
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of the phosphatidylinositol 3-kinase/Akt pathway is involved in BMP9-mediated tumor-suppressive effects in gastric cancer cells.
Duan L; Ye L; Wu R; Wang H; Li X; Li H; Yuan S; Zha H; Sun H; Zhang Y; Chen X; Zhang Y; Zhou L
J Cell Biochem; 2015 Jun; 116(6):1080-9. PubMed ID: 25640278
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 supports stemness in ovarian cancer stem cells by activation of the Notch1 intracellular domain.
Kang HG; Kim DH; Kim SJ; Cho Y; Jung J; Jang W; Chun KH
Oncotarget; 2016 Oct; 7(42):68229-68241. PubMed ID: 27626163
[TBL] [Abstract][Full Text] [Related]
11. BMP9 inhibits the proliferation and invasiveness of breast cancer cells MDA-MB-231.
Wang K; Feng H; Ren W; Sun X; Luo J; Tang M; Zhou L; Weng Y; He TC; Zhang Y
J Cancer Res Clin Oncol; 2011 Nov; 137(11):1687-96. PubMed ID: 21892652
[TBL] [Abstract][Full Text] [Related]
12. Epithelial‑mesenchymal transition induced by bone morphogenetic protein 9 hinders cisplatin efficacy in ovarian cancer cells.
Wang Y; Yang B; Zhao J; Yu X; Liu X; Zhang L; Zhang Y; Li X; Zhai Z
Mol Med Rep; 2019 Mar; 19(3):1501-1508. PubMed ID: 30628686
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA‑455 inhibits cell proliferation and invasion of epithelial ovarian cancer by directly targeting Notch1.
Xu L; Li H; Su L; Lu Q; Liu Z
Mol Med Rep; 2017 Dec; 16(6):9777-9785. PubMed ID: 29039517
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer.
Liu MX; Siu MK; Liu SS; Yam JW; Ngan HY; Chan DW
Oncotarget; 2014 Feb; 5(4):944-58. PubMed ID: 24659709
[TBL] [Abstract][Full Text] [Related]
15. BMP9-ID1 Signaling Activates HIF-1α and VEGFA Expression to Promote Tumor Angiogenesis in Hepatocellular Carcinoma.
Chen H; Nio K; Tang H; Yamashita T; Okada H; Li Y; Doan PTB; Li R; Lv J; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163396
[TBL] [Abstract][Full Text] [Related]
16. SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway.
Zhu W; Niu J; He M; Zhang L; Lv X; Liu F; Jiang L; Zhang J; Yu Z; Zhao L; Bi J; Yan Y; Wei Q; Huo H; Fan Y; Chen Y; Ding J; Wei M
J Transl Med; 2019 Aug; 17(1):259. PubMed ID: 31395064
[TBL] [Abstract][Full Text] [Related]
17. Impact of selective anti-BMP9 treatment on tumor cells and tumor angiogenesis.
Brand V; Lehmann C; Umkehrer C; Bissinger S; Thier M; de Wouters M; Raemsch R; Jucknischke U; Haas A; Breuer S; Birzele F; Racek T; Reis M; Lorenzon E; Herting F; Stürzl M; Lorenz S; Kienast Y
Mol Oncol; 2016 Dec; 10(10):1603-1620. PubMed ID: 28949445
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-433 inhibits migration and invasion of ovarian cancer cells via targeting Notch1.
Liang T; Guo Q; Li L; Cheng Y; Ren C; Zhang G
Neoplasma; 2016; 63(5):696-704. PubMed ID: 27468873
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein‑9 promotes the differentiation of mouse spleen macrophages into osteoclasts via the ALK1 receptor and ERK 1/2 pathways in vitro.
Li H; Zhao D; Wang S; Ding J; Zhao L
Mol Med Rep; 2016 Nov; 14(5):4545-4550. PubMed ID: 27748860
[TBL] [Abstract][Full Text] [Related]
20. BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.
Ouarné M; Bouvard C; Boneva G; Mallet C; Ribeiro J; Desroches-Castan A; Soleilhac E; Tillet E; Peyruchaud O; Bailly S
J Exp Clin Cancer Res; 2018 Aug; 37(1):209. PubMed ID: 30165893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]